Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Integrated nanosensors to determine levels and functional activity of human telomerase.

Perez JM, Grimm J, Josephson L, Weissleder R.

Neoplasia. 2008 Oct;10(10):1066-72.

2.

Label-free highly sensitive detection of telomerase activity in cancer cell by chemiluminescence imaging.

Ma C, Xia K, Chen H, Zeng W, Han R, Tang J.

Mol Cell Probes. 2012 Oct;26(5):212-4. doi: 10.1016/j.mcp.2012.06.002. Epub 2012 Jun 26.

PMID:
22750567
3.

Targeting the telosome: therapeutic implications.

Folini M, Gandellini P, Zaffaroni N.

Biochim Biophys Acta. 2009 Apr;1792(4):309-16. doi: 10.1016/j.bbadis.2009.01.014. Epub 2009 Feb 5. Review.

4.

Novel nanosensors for rapid analysis of telomerase activity.

Grimm J, Perez JM, Josephson L, Weissleder R.

Cancer Res. 2004 Jan 15;64(2):639-43.

5.

[Telomerase--new diagnostic and therapeutic options in oncology].

Rakoval AL, Bokarev IN, Rezvan VV.

Voen Med Zh. 2000 Nov;321(11):26-9, 96. Review. Russian.

PMID:
11302101
6.

Telomerase as a diagnostic and therapeutic target for cancer.

Doyle LA, Highsmith WE.

Expert Rev Anticancer Ther. 2002 Apr;2(2):217-25. Review.

PMID:
12113243
7.

Detection of telomerase activity by the TRAP assay and its variants and alternatives.

Fajkus J.

Clin Chim Acta. 2006 Sep;371(1-2):25-31. Epub 2006 Apr 17. Review.

PMID:
16616059
8.

PCR-free and label-free fluorescent detection of telomerase activity at single-cell level based on triple amplification.

Gao Y, Xu J, Li B, Jin Y.

Biosens Bioelectron. 2016 Jul 15;81:415-422. doi: 10.1016/j.bios.2016.03.022. Epub 2016 Mar 12.

PMID:
26999622
9.

Screening with COMPARE analysis for telomerase inhibitors.

Naasani I, Yamori T, Tsuruo T.

Methods Mol Biol. 2002;191:197-207. Review. No abstract available.

PMID:
11951607
10.

Targeting human telomerase in cancer therapy.

Huard S, Autexier C.

Curr Med Chem Anticancer Agents. 2002 Sep;2(5):577-87. Review.

PMID:
12678725
11.

Telomerase: a target for cancer therapeutics.

Shay JW, Wright WE.

Cancer Cell. 2002 Oct;2(4):257-65. Review.

12.

Telomerase assay as a possible predictor of the response to anticancer chemotherapy.

Terashima M, Takiyama I, Uesugi N, Sasaki N, Takagane A, Hayakawa Y, Abe K, Araya M, Nishizuka S, Shimooki O, Nakaya T, Irinoda T, Yonezawa H, Oyama K, Saito K.

Anticancer Res. 2000 Jan-Feb;20(1A):293-7.

PMID:
10769670
13.

Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples.

Faraoni I, Graziani G, Turriziani M, Masci G, Mezzetti M, Testori A, Veronesi U, Bonmassar E.

Lab Invest. 1999 Aug;79(8):993-1005.

PMID:
10462037
14.

Detection of activity of telomerase in tumor cells using fiber optical biosensors.

Schmidt PM, Lehmann C, Matthes E, Bier FF.

Biosens Bioelectron. 2002 Dec;17(11-12):1081-87.

PMID:
12392959
15.

Amplified telomerase analysis by using rotating magnetic particles: the rapid and sensitive detection of cancer cells.

Weizmann Y, Patolsky F, Katz E, Willner I.

Chembiochem. 2004 Jul 5;5(7):943-8.

PMID:
15239051
16.
17.

Determination of telomerase activity and telomere length.

Wu KD, Moore MA.

Methods Mol Med. 2005;113:207-23.

PMID:
15968105
18.

Assays for human telomerase activity: progress and prospects.

Zhou X, Xing D.

Chem Soc Rev. 2012 Jul 7;41(13):4643-56. doi: 10.1039/c2cs35045a. Epub 2012 May 1. Review.

PMID:
22546968
19.

Design of telomerase inhibitors for the treatment of cancer.

Cairns D, Anderson RJ, Perry PJ, Jenkins TC.

Curr Pharm Des. 2002;8(27):2491-504. Review.

PMID:
12369943
20.

Magneto-mechanical detection of nucleic acids and telomerase activity in cancer cells.

Weizmann Y, Patolsky F, Lioubashevski O, Willner I.

J Am Chem Soc. 2004 Feb 4;126(4):1073-80.

PMID:
14746475

Supplemental Content

Support Center